Earnings
PHAR
14.50
-0.97%
-0.14
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
189.47M
189.47M
23.94M
165.53M
65.95M
31.80M
--
--
-487.63K
121.20M
--
68.28M
-12.72M
--
-3.23M
-12.72M
52.33M
11.75M
40.57M
--
40.57M
40.57M
--
--
0.06
FY 2018-12-31
154.90M
154.90M
25.42M
129.47M
53.60M
33.11M
--
--
-784.07K
111.35M
--
43.55M
-18.27M
--
-24.30M
-18.27M
982.38K
-27.67M
28.65M
--
28.65M
28.65M
--
--
0.04
FY 2017-12-31
108.05M
108.05M
15.00M
93.05M
45.09M
22.49M
--
--
-952.50K
81.64M
--
26.42M
-66.90M
--
-62.84M
-66.90M
-103.32M
-11.38M
-91.93M
--
-91.93M
-91.93M
--
--
-0.18
FY 2016-12-31
16.74M
16.74M
4.94M
11.80M
8.10M
16.23M
--
--
-353.29K
28.91M
--
-12.17M
-3.71M
--
-2.62M
-3.71M
-18.49M
0.00
-18.49M
--
-18.49M
-18.49M
--
--
-0.04
FY 2015-12-31
11.76M
11.76M
5.21M
6.55M
5.25M
15.40M
--
--
-159.67K
25.70M
--
-13.94M
3.12M
--
--
3.12M
-10.82M
0.00
-10.82M
--
-10.82M
-10.82M
--
--
-0.03

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PHAR latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Pharming Group N.V. recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.